Literature DB >> 2072428

Pneumonia: incidence, risk factors, and outcome in injured patients.

J L Rodriguez1, K J Gibbons, L G Bitzer, R E Dechert, S M Steinberg, L M Flint.   

Abstract

One hundred thirty (44.2%) of 294 patients hospitalized for trauma and admitted to the Surgical Intensive Care Unit for mechanical ventilation developed hospital-acquired bacterial pneumonia. The predominant pathogens isolated were gram-negative enteric bacilli (72%), but there was not an increase in mortality associated with gram-negative pneumonia compared with similar patients without pneumonia. Of the seven admission risk factors univariately associated with the development of acquired bacterial pneumonia, only emergent intubation (p less than 0.001), head injury (p less than 0.001), hypotension on admission (p less than 0.001), blunt trauma as the mechanism of injury (p less than 0.001), and Injury Severity Score (p less than 0.001) remained significant after stepwise logistic regression. Not surprisingly, as mechanical ventilation is continued, the probability of pneumonia emerging increases. The consequences of hospital-acquired bacterial pneumonia are a significant seven-, five-, and two-fold increase in mechanically ventilated days, intensive care, and hospital stay, respectively. We conclude that the incidence of hospital-acquired pneumonia in injured patients admitted to the ICU for mechanical ventilation occurs in nearly half the patients, is associated with specific risk factors, and significantly increases morbidity but does not increase mortality.

Entities:  

Mesh:

Year:  1991        PMID: 2072428

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  29 in total

1.  Proinflammatory cytokine surge after injury stimulates an airway immunoglobulin a increase.

Authors:  Mark A Jonker; Yoshifumi Sano; Joshua L Hermsen; Jinggang Lan; Kenneth A Kudsk
Journal:  J Trauma       Date:  2010-10

2.  Risk factors for late-onset ventilator-associated pneumonia in trauma patients receiving selective digestive decontamination.

Authors:  Marc Leone; Stéphane Delliaux; Aurélie Bourgoin; Jacques Albanèse; Franck Garnier; Ioana Boyadjiev; Francois Antonini; Claude Martin
Journal:  Intensive Care Med       Date:  2004-12-02       Impact factor: 17.440

Review 3.  Role of nonsynaptic communication in regulating the immune response.

Authors:  Zsolt Selmeczy; E Sylvester Vizi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Neurochem Int       Date:  2007-06-17       Impact factor: 3.921

4.  Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study.

Authors:  M A Croce; T C Fabian; L Waddle-Smith; S M Melton; G Minard; K A Kudsk; F E Pritchard
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

Review 5.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

6.  Bilateral versus unilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia.

Authors:  Mark A Jonker; Tina M Sauerhammer; Lee D Faucher; Michael J Schurr; Kenneth A Kudsk
Journal:  Surg Infect (Larchmt)       Date:  2012-12-16       Impact factor: 2.150

7.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Pneumonia in the surgical intensive care unit. Immunologic keys to the silent epidemic.

Authors:  W Naziri; W G Cheadle; J D Pietsch; S Appel; H C Polk
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

9.  Optimal therapy for stress gastritis.

Authors:  R V Maier; D Mitchell; L Gentilello
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Antibiotic prophylaxis for intracranial pressure monitors.

Authors:  D G Jacobs; A Westerband
Journal:  J Natl Med Assoc       Date:  1998-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.